Tudor Investment Corp’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
FLAM
AIC
SM
RHJA
KCM
Tudor Investment Corp's OPRX Position: Q3 2024 in Review
Tudor Investment Corp sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 30,519 shares — an estimated $305K sold.
Tudor Investment Corp first reported a position in OPRX in Q1 2021 and held it in 10 quarters. The position peaked at $1.27M in Q2 2021. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.
- Tudor Investment Corp reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
- Tudor Investment Corp sold 30,519 OptimizeRx shares in Q3 2024, an estimated $305K.
- Tudor Investment Corp first reported a position in OptimizeRx in Q1 2021 and held it in 10 quarters.
- Tudor Investment Corp's OptimizeRx position peaked at $1.27M in Q2 2021.
- 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.